CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONFIRMING SUSTAINED BENEFIT AND SAFETY OF ITS ATRIAL SHUNT IN HEART FAILURE PATIENTS

/PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced two-year results from its REDUCE...

Related Keywords

Prague ,Praha ,Hlavníesto ,Czech Republic ,Australia ,Copenhagen ,Køavn ,Denmark ,Lisa Ensz ,Jan Komtebedde ,Edwards Lifesciences ,Finn Gustafsson ,Sanjiv Shah ,Corvia Medical Inc ,University Of Copenhagen ,Northwestern University Feinberg School Of Medicine ,European Society Of Cardiology ,Prnewswire Corvia Medical Inc ,Atrial Shunt ,European Society ,Heart Failure ,Corvia Atrial Shunt ,Kansas City Cardiomyopathy Questionnaire ,Northwestern University Feinberg School ,Corvia Atrial ,Corvia Medical ,Breakthrough Device ,Third Rock Ventures ,General Catalyst Partners ,Lumira Ventures ,Nc ,